Nanobiotix S.A. ADR (NBTX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2019 | 12-2017 | 12-2006 | |
| Assets | |||
| Current Assets | |||
| Cash & Cash Equivalents | 39,305 | N/A | N/A |
| Receivables | 12 | N/A | N/A |
| Other current assets | 12,345 | 0 | 0 |
| TOTAL | $51,662 | $N/A | $N/A |
| Non-Current Assets | |||
| PPE Net | 10,512 | N/A | N/A |
| Investments And Advances | 593 | 0 | 0 |
| Intangibles | 183 | 0 | 0 |
| TOTAL | $11,287 | $N/A | $N/A |
| Total Assets | $62,950 | $N/A | $N/A |
| Liabilities | |||
| Current Liabilities | |||
| Accounts payable and accrued liabilities | 8,702 | 0 | 0 |
| Other current liabilities | 7,366 | N/A | N/A |
| TOTAL | $16,069 | $N/A | $N/A |
| Non-Current Liabilities | |||
| Other Non-Current Liabilities | 49,018 | 0 | 0 |
| TOTAL | $49,018 | $N/A | $N/A |
| Total Liabilities | $65,087 | $N/A | $N/A |
| Shareholders' Equity | |||
| Common Shares | 753 | N/A | N/A |
| Retained earnings | -57,025 | N/A | N/A |
| Other shareholders' equity | -117,381 | 0 | 0 |
| TOTAL | $-2,137 | $N/A | $N/A |
| Total Liabilities And Equity | $62,950 | $0 | $0 |